RECURRENT CERVICAL CANCER
Clinical trials for RECURRENT CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cervical cancer: phase 3 trial of SHR-A2102 begins
Disease control Recruiting nowThis study tests a new drug, SHR-A2102, against standard chemotherapy in about 398 people with recurrent or metastatic cervical cancer that has not responded to platinum-based chemo and immunotherapy. The goal is to see if SHR-A2102 helps people live longer. Participants must hav…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:55 UTC
-
New combo therapy offers hope for advanced cervical cancer patients
Disease control Recruiting nowThis clinical trial is testing a new treatment approach for people with cervical cancer that has spread, come back, or not gone away after standard treatment. The study combines immunotherapy drugs (PD-1/PD-L1 inhibitors) with chemotherapy, with or without another targeted drug (…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated May 26, 2026 10:55 UTC